Funding for this research was provided by:
Text and Data Mining valid from 2019-10-30
Received: 13 February 2019
Accepted: 23 September 2019
First Online: 30 October 2019
Ethics approval and consent to participate
: Ethics approval was obtained from Copernicus Review Board (KJT1–15-499). Prior to completing surveys, respondents provided informed consent electronically. The paper contains no identifying information.
: Not applicable.
: Dr. Dhurandhar reports personal fees from Novo Nordisk during the conduct of the study and personal fees from Novo Nordisk outside the submitted work. He has also received an investigator-initiated grant from Novo Nordisk.Mr. Kyle reports personal fees from Novo Nordisk, during the conduct of the study; personal fees from Eisai, personal fees from NutriSystem, outside the submitted work.Dr. Stevenin is an employee of Novo Nordisk, Inc.Dr. Tomaszewski reports consulting fees from Novo Nordisk during the conduct of the study.